PUBLISHER: Grand View Research | PRODUCT CODE: 1985869
PUBLISHER: Grand View Research | PRODUCT CODE: 1985869
The global medical stampings market size was estimated at USD 9.56 billion in 2025 and is projected to reach USD 43.02 billion by 2035, growing at a CAGR of 16.1% from 2026 to 2035. This growth is driven by the rising prevalence of chronic diseases such as cancer, diabetes, and other disorders, along with the increasing number of surgical procedures.
Technological advancements and the rising adoption of wearable devices are likely to increase demand for stamping components. Additionally, expanding healthcare infrastructure, and growing awareness about early diagnosis and treatment are fueling adoption of advanced medical stamping solutions globally.
The increasing burden of chronic and noncommunicable diseases (NCDs) is a major driver for the medical stampings industry. According to the World Health Organization, NCDs account for roughly 74 % of all deaths worldwide, with cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases being the leading causes. The rising prevalence of diabetes is also contributing to the market growth. For example, in OECD countries, the age-standardized prevalence of diabetes among adults reached 8.6% in 2022, while millions more remain undiagnosed. Cardiovascular disease (CVD), another major NCD, continues to escalate in 2023. CVD caused 19.2 million deaths globally, with metabolic risk factors such as high BMI and elevated blood sugar contributing significantly. Meanwhile, in the U.S., 76.4% of adults, or roughly 194 million people, reported having at least one chronic condition as of 2023, and 51.4% reported having multiple chronic conditions. This ongoing rise in chronic disease prevalence is driving demand for long-term medical devices, including stents, insulin pumps, orthopedic implants, and diagnostic tools that rely on precision-stamped metal components.
The rising volume of health-care waste and growing attention to its environmental impact are pushing medical device manufacturers and hospitals to cut waste across the product lifecycle. Globally, about 85% of health-care waste is non-hazardous, and 15% is hazardous, creating a large stream of material that needs safe handling and reduction. The COVID-19 period sharply increased single-use medical waste and highlighted vulnerabilities in waste management systems, prompting regulators and health systems to prioritize waste minimization and circular practices. For medical stamping manufacturers, sustainability is becoming a key priority. Medical device manufacturers are now looking for stamping processes that generate less scrap, support recycling, and use less energy during production. Metal stamping already has an advantage because ferrous metals are highly recyclable and form one of the world's largest recycling streams. This helps medical device makers reduce their reliance on new raw materials and meet circular-economy goals.
Manufacturers are also upgrading their production equipment to improve efficiency. Newer technologies, such as servo-driven or servo-electric presses, use less energy and place lower demand on peak power compared with older mechanical or hydraulic machines. Many companies report energy savings of up to 30% after switching to these systems, along with significant reductions in peak electricity usage. This helps reduce both the carbon footprint and the operating costs of medical stamping operations. These measures make stamped components more appealing to OEMs that want reliable, sustainable, and cost-efficient supply chains.
Global Medical Stampings Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. Forthis study, Grand View Research has segmented the global medical stampings market report based on product, application, and region: